HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

MelanX topical methyl xanthine agent stimulates natural pigmentation; clinicals planned.

This article was originally published in The Rose Sheet

Executive Summary

MELANX TOPICAL METHYL XANTHINE PIGMENTATION AGENT PROVIDES "NATURAL TAN" without sun exposure by stimulating melanin production, Byran Fuller, PhD, University of Oklahoma Health Science Center, said at the Drug Discovery Approaches for Developing Cosmeceuticals conference in East Rutherford, N.J. Jan. 29-31. Unlike conventional sunless tanning products that "stain" the top layer of the skin, the investigational MelanX topical agent MX-100 activates tyrosinase, the melanocyte enzyme responsible for manufacturing melanin, Fuller explained. The activated melanocytes produce large amounts of melanin in the epidermis, which are carried to the skin's surface by keratinocytes, resulting in increased skin pigmentation, he explained.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS003773

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel